• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 10676
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Vascular Dissection (3160)
Event Date 12/23/2021
Event Type  Injury  
Event Description
It was reported that a dissection occurred.A percutaneous transluminal coronary angioplasty was performed on the 100% stenosed, 30 x 3.50mm, target lesion located in a moderately tortuous and non-calcified mid right coronary artery (rca).Following pre-dilation, 32 x 3.50 promus elite mr was deployed in the rca.Following stent deployment, a proximal edge dissection was noted.It was noted that the dissection was a type b dissection, and was flow limiting.Another drug eluting stent was deployed to cover the dissection and complete the procedure.No further patient complications were reported and the patient status was fully recovered.
 
Event Description
It was reported that a dissection occurred.A percutaneous transluminal coronary angioplasty was performed on a mid right coronary artery (rca).A 32 x 3.50 promus elite mr was deployed in the rca.Following stent deployment, a proximal edge dissection was noted.It was noted that the dissection was a type b dissection, and was flow limiting.Another drug eluting stent was deployed to cover the dissection and complete the procedure.No further patient complications were reported and the patient status was fully recovered.It was further reported that vascular access was obtained via the right radial artery.The 100% stenosed, 30 x 3.50mm, target lesion was located in the moderately tortuous and non-calcified rca.It was noted that the lesion was predilated and was post dilated.The dissection was noticed after the promus elite stent implantation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELITE
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13191651
MDR Text Key283401781
Report Number2134265-2021-16539
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/12/2022
Device Model Number10676
Device Catalogue Number10676
Device Lot Number0026439107
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/28/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/12/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-